Literature DB >> 20437440

Iridium complex with antiangiogenic properties.

Alexander Wilbuer1, Danielle H Vlecken, Daan J Schmitz, Katja Kräling, Klaus Harms, Christoph P Bagowski, Eric Meggers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20437440     DOI： 10.1002/anie.201000682

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  24 in total

1.  Organometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors.

Authors:  Sebastian Blanck; Thomas Cruchter; Adina Vultur; Radostan Riedel; Klaus Harms; Meenhard Herlyn; Eric Meggers
Journal:  Organometallics       Date:  2011-07-18       Impact factor: 3.876

2.  The art of filling protein pockets efficiently with octahedral metal complexes.

Authors:  Sebastian Blanck; Jasna Maksimoska; Julia Baumeister; Klaus Harms; Ronen Marmorstein; Eric Meggers
Journal:  Angew Chem Int Ed Engl       Date:  2012-03-01       Impact factor: 15.336

3.  Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition.

Authors:  Sebastian Blanck; Yann Geisselbrecht; Katja Kräling; Stephen Middel; Thomas Mietke; Klaus Harms; Lars-Oliver Essen; Eric Meggers
Journal:  Dalton Trans       Date:  2012-06-26       Impact factor: 4.390

4.  Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors.

Authors:  Li Feng; Yann Geisselbrecht; Sebastian Blanck; Alexander Wilbuer; G Ekin Atilla-Gokcumen; Panagis Filippakopoulos; Katja Kräling; Mehmet Ali Celik; Klaus Harms; Jasna Maksimoska; Ronen Marmorstein; Gernot Frenking; Stefan Knapp; Lars-Oliver Essen; Eric Meggers
Journal:  J Am Chem Soc       Date:  2011-03-29       Impact factor: 15.419

5.  Novel Quinoline-based Ir(III) Complexes Exhibit High Antitumor Activity in Vitro and in Vivo.

Authors:  Yan Yang; Yi-Dong Bin; Qi-Pin Qin; Xu-Jian Luo; Bi-Qun Zou; Hua-Xin Zhang
Journal:  ACS Med Chem Lett       Date:  2019-11-06       Impact factor: 4.345

6.  Hybrid organic-inorganic inhibitors of a PDZ interaction that regulates the endocytic fate of CFTR.

Authors:  Rituparna Kundu; Patrick R Cushing; Brian V Popp; Yu Zhao; Dean R Madden; Zachary T Ball
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-14       Impact factor: 15.336

7.  Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3β.

Authors:  G Ekin Atilla-Gokcumen; Luigi Di Costanzo; Eric Meggers
Journal:  J Biol Inorg Chem       Date:  2010-09-07       Impact factor: 3.358

8.  Ligand-Controlled Reactivity and Cytotoxicity of Cyclometalated Rhodium(III) Complexes.

Authors:  Wen-Ying Zhang; Hannah E Bridgewater; Samya Banerjee; Joan J Soldevila-Barreda; Guy J Clarkson; Huayun Shi; Cinzia Imberti; Peter J Sadler
Journal:  Eur J Inorg Chem       Date:  2019-11-20       Impact factor: 2.524

9.  Ligand-centred redox activation of inert organoiridium anticancer catalysts.

Authors:  Wen-Ying Zhang; Samya Banerjee; George M Hughes; Hannah E Bridgewater; Ji-Inn Song; Ben G Breeze; Guy J Clarkson; James P C Coverdale; Carlos Sanchez-Cano; Fortuna Ponte; Emilia Sicilia; Peter J Sadler
Journal:  Chem Sci       Date:  2020-05-15       Impact factor: 9.825

10.  A metal-based inhibitor of NEDD8-activating enzyme.

Authors:  Hai-Jing Zhong; Hui Yang; Daniel Shiu-Hin Chan; Chung-Hang Leung; Hui-Min Wang; Dik-Lung Ma
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.